AdvisorShares Investments’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Buy |
396,514
+120,000
| +43% | +$72K | 0.04% | 215 |
|
|
2025
Q1 | $75.7K | Buy |
276,514
+66,446
| +32% | +$18.2K | 0.01% | 256 |
|
|
2024
Q4 | $109K | Buy |
210,068
+141,540
| +207% | +$73.6K | 0.02% | 245 |
|
|
2024
Q3 | $222K | Sell |
68,528
-21,500
| -24% | -$69.7K | 0.04% | 211 |
|
|
2024
Q2 | $276K | Buy |
90,028
+19,975
| +29% | +$61.3K | 0.05% | 207 |
|
|
2024
Q1 | $326K | Sell |
70,053
-4,613
| -6% | -$21.5K | 0.05% | 202 |
|
|
2023
Q4 | $309K | Sell |
74,666
-38,242
| -34% | -$158K | 0.07% | 204 |
|
|
2023
Q3 | $339K | Buy |
112,908
+10
| +0% | +$30 | 0.09% | 167 |
|
|
2023
Q2 | $278K | Buy |
112,898
+8,758
| +8% | +$21.5K | 0.08% | 185 |
|
|
2023
Q1 | $235K | Buy |
104,140
+22,778
| +28% | +$51.5K | 0.07% | 180 |
|
|
2022
Q4 | $284K | Buy |
81,362
+70,904
| +678% | +$247K | 0.08% | 197 |
|
|
2022
Q3 | $387K | Buy |
+10,458
| New | +$387K | 0.1% | 185 |
|